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ANALISIS EKSPRESI GEN SEL TUNJANG DARIPADA GIGI SUSU 
TERKELUPAS DALAM PROSES MIGRASI DAN ANGIOGENIK 
SETEMPAT UNTUK PEMBAIKIAN TISU 
ABSTRAK 
Sel tunjang memainkan peranan penting semasa proses angiogenik 
(pembentukan tisu salur darah) semasa proses pembaikan tisu. Sel tunjang daripada 
gigi susu yang terkelupas (SHED) memiliki ciri-ciri sel tunjang mesenkima (MSC) 
yang menunjukkan kebolehan untuk membentuk pelbagai susur galur sekaligus 
menunjukkan potensinya yang besar untuk bermanfaat kepada terapi berasaskan sel 
dan pemulihan tisu. Walau bagaimanapun, keupayaan migrasi dan ekspresi gen oleh 
SHED semasa proses angiogenik belum dapat difahami sepenuhnya. Kajian ini 
menyasarkan untuk menentukan perbezaan pola ekspresi gen SHED yang bermigrasi 
dan melalui perubahan angiogenik. Kesan perbezaan ketumpatan awal pembenihan 
dan media aruhan ke atas migrasi SHED turut dikaji. Secara ringkasnya, SHED 
dikembang biakkan secara in vitro dan kemudian dikultur menggunakan 10 ng/ml 
faktor pertumbuhan endotelium vaskular (VEGF) dalam 2 ml medium pertumbuhan 
endotelium 2 (EGM2). Kajian gores dijalankan di dalam ruang transwell untuk 
menentukan kadar ketumpatan pembenihan permulaan SHED yang optimum dengan 
membandingkan 5,000 sel/cm2 dan 10,000 sel/cm2 sebelum aruhan angiogenik. 
Perbandingan lanjut telah dibuat untuk melihat kesan media aruhan angiogenik ke atas 
kadar migrasi SHED. Tiga kumpulan SHED telah dikembangkan untuk mengkaji 
ekspresi gen; kumpulan aruhan angiogenik (+A-M), kumpulan aruhan angiogenik 
dengan migrasi (+A+M), dan kumpulan pemalar (-A-M). RNA diekstrak pada titik 
masa yang berbeza (hari 1, 3, 7, 10 dan 14). RT-PCR Satu Langkah telah dijalankan 
xiv 
 
untuk menaksir tahap ekspresi gen untuk siri penanda gen angiogenik, migrasi dan 
MSC. Secara umum, data menunjukkan keupapayaan SHED untuk membentuk sel 
daripada susur galur angiogenik. Ketumpatan pembenihan yang tinggi dapat 
meningkatkan kadar migrasi SHED manakala proses aruhan angiogenik didapati telah 
mengurangkan kadar migrasi SHED. SHED didapati positif untuk penanda gen 
angiogenik; Ang-1, IL-8 dan VE-Cadherin serta gen migrasi; CCR1, CXCR4 dan 
CCL28. Malah, SHED juga mengekalkan ekspresi semua penanda gen MSC iaitu 
CD73, CD90 and CD105, walaupun selepas aruhan. Pola ekspresi gen angiogenik dan 
gen migrasi oleh SHED menunjukkan cabaran dalam memahami kedua-dua proses 
tersebut yang terlibat dalam proses pembaikan tisu. Namun, kefahaman yang lebih 
baik tentang interaksi SHED-chemokine adalah amat diperlukan untuk membolehkan 
















GENE EXPRESSION ANALYSIS OF STEM CELL FROM EXFOLIATED 
DECIDUOUS TEETH IN MIGRATION AND LOCAL ANGIOGENESIS OF 
TISSUE REPAIR 
ABSTRACT 
Stem cells play essential role during the angiogenesis process of wound 
healing. Stem cells from exfoliated deciduous teeth (SHED) possess mesenchymal 
stem cell (MSC) characteristics, showing the ability to differentiate into various 
lineages, indicating their massive potential to benefit cell-based therapy and tissue 
repair. Nevertheless, the behaviour of SHED engaging in angiogenesis in terms of its 
migratory capacity and gene expression regulation remains questionable. The present 
study aims to analyse the gene expression pattern of SHED undergoing migration and 
angiogenic differentiation. Together, the effect of different initial seeding density and 
induction medium on the migration of SHED were assessed. SHED were expanded in 
vitro and induced for angiogenesis by supplementation of 10 ng/ml of vascular 
endothelial growth factor (VEGF) in 2 ml of endothelial growth medium 2 (EGM2). 
Scratch test assay was conducted in the transwell chamber to determine the optimum 
initial seeding density for SHED by comparing 5,000 cells/cm2 and 10,000 cells/cm2 
prior to angiogenic induction. A further comparison was made to assess the effect of 
angiogenic induction media on SHED migration rate. Three groups of SHED were 
assessed the gene expression analysis: the angiogenic induction group (+A-M), 
angiogenic induction with migration group (+A+M), and the control group (-A-M). 
RNA was extracted at different time points (day 1, 3, 7, 10 and 14). One-step RT-PCR 
was then performed to assess the gene expression level of a series of angiogenic, 
migration and MSC gene markers. Overall, the data demonstrated a high capability of 
xvi 
 
SHED committing to angiogenic lineage. Higher seeding density (10,000 cells/cm2) 
increased SHED migration, whereas angiogenic induction suppressed SHED 
migratory capacity. SHED positively expressed Ang-1, Il-8, and VE-Cadherin, the 
angiogenic markers, as well as the migratory gene markers (CCR1, CXCR4 and 
CCL28). SHED also maintains the stemness level by positive expression of CD73, 
CD90 and CD105 during the induction protocol. The gene expression pattern of both 
angiogenic and migratory gene markers observed within this study indicate the 
complexity of understanding these two events during tissue repair. Indeed, a better 
understanding of these SHED-chemokine interactions is needed to enable the effective 






   CHAPTER 1: INTRODUCTION 
1.1 Background of the study 
Wound healing begins when bleeding occurs. Angiogenic blood and coagulant 
proteins enter the wound site, followed by growth factors that were produced by 
inflammatory cells, metabolic by-products and coagulation proteins (Hunt et al., 
2008).  Macrophages were recruited to the wound bed and stimulate the proliferation 
of fibroblasts,  keratinocytes, endothelial cells, epithelial cells and connective tissues 
to induce extracellular matrix formation, neovascularisation and reepithelialisation 
(Delavary et al., 2011). Next, in response to high metabolic needs at the wound area, 
fibroblast will help to form the extracellular matrix. At the same time, endothelial cells 
will line the capillary tubes to repair the blood flow (Schugart et al., 2008). The final 
stage of wound healing involves the maturation of the granulation tissue which forms 
mature connective tissues or an avascular scar (Enoch and Leaper, 2008; Strodtbeck, 
2001). Positive outcomes in tissue repair can be achieved through an effective 
approach to wound healing. 
Efficient wound management is fundamental in all living organisms. The discovery of 
the importance of stem cells as therapeutic agents in wound treatment has gained much 
interest from the public in recent years. The used of stem cells in cell-based therapies 
helps in achieving the primary aim of wound treatment; a rapid closure of the lesion 
along with a functional and aesthetically satisfactory scar (de Mendonça, 2012). 
Moreover, the transplanted stem cells can assist the healing of an acute and chronic 
wound by differentiating into multiple types of cells and providing cytokines and 
growth factors needed by the healing area, making the process simple and less time-
consuming (Kim and Suh, 2010; You and Han, 2014). 
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Stem cells are unspecialised biological cells that can differentiate into committed cells 
by undergoing self-regeneration. In dentistry, stem cells offer great potential in 
providing better treatment modalities for the patients. Stem cell-based therapies could 
help in new advances in treating damaged teeth, inducing bone regeneration and 
treating neural injury (Narang and Sehgal, 2012). In general, there are three significant 
types of stem cells in regenerative medicine; the embryonic stem cells, adult stem cells 
and induced pluripotent stem cells.  
One of the most advanced types of medical-scientific approach in clinical applications 
includes adult stem cells research. Among the various sources of adult stem cells, an 
immature stem cell population from human exfoliated deciduous (primary) teeth 
(SHED) were successfully isolated and characterised (Martinez Saez et al., 2016). 
SHED are progenitor cells isolated from the pulp remnant of exfoliated (natural 
resorption of primary tooth’s root) deciduous teeth. SHED are highly proliferative 
cells, possessing a clonogenic capacity to differentiate into a variety of cell types, such 
as neural cells, adipocytes, and odontoblasts (Goomer et al., 2014; Park et al., 2016). 
SHED remain feasible, convenient and affordable to collect, which hold promise for a 
range of potential therapeutic applications (Bansal and Jain, 2015).  
Transplanted SHED were found to provide therapeutic potential in liver regeneration 
since it improves the hepatic dysfunction in primary and secondary recipients and 
directly transform into hepatocytes without cell fusion in carbon tetrachloride-treated 
mice (Yamaza et al., 2015). SHED may potentially be used in the treatment of immune 
disorders such as SLE and ischemic kidney injury by reversing the damaging effects 
of the disease (Hattori et al., 2015; Yamaza et al., 2010). Despite the increasing 
researches conducted on SHED, the information is still lacking to enable SHED usage 
in regenerative therapy.   
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Angiogenesis is the physiological and pathological formation of blood vessels from 
the existing vasculature (Adair and Montani, 2010; Michaelis, 2014). In the early stage 
of tissue repair, angiogenesis helps to provide nutrients and oxygen to the reparative 
cells through the restoration of blood flow to the damaged tissue, marking the 
beginning of a healing response (Johnson and Wilgus, 2014; Willenborg et al., 2012). 
Increasing the efficiency of directional stem cell homing might directly increase the 
process of angiogenesis and subsequently accelerate wound healing time. Since 
uncontrolled angiogenesis has long been associated with invasive tumour growth, 
metastasis, and cancer progression, the process of angiogenesis in tissue repair must 
be precisely controlled and monitored to avoid such events.  
Another vital aspect in tissue reconstruction is the homing process, which refers to the 
migratory capacity of progenitor cells to travel from the neighbouring area to the 
damage site and further support the process of new tissue formation.  The delivery or 
migration of stem cells to the damaged area is influenced by multiple factors including 
age and passage number of the cells, culture conditions, and the delivery method 
(Khaldoyanidi, 2008; Sohni and Verfaillie, 2013). Studies on angiogenesis have 
gained much interest in recent years due to their essential role in regulating the critical 
event in tissue regeneration. Endothelial cell migration is essential to angiogenesis as 
chemotactic, hepatotactic and mechanotactic stimuli directionally regulate this process 
and further involves in the degradation of the extracellular matrix to enable the 
progression of the migrating cell (Lamalice et al., 2007).  
Previously, cellular migration during angiogenesis has been performed using various 
type of cells, including the human umbilical vein endothelial cells (HUVEC), 
endothelial cells (EC) and human dental pulp stem cells (hDPSC) (Ausprunk and 
Folkman, 1977; Bronckaers et al., 2013; Daub and Merks, 2013; Dissanayaka et al., 
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2014; Kang et al., 2016). HUVEC proved to have a high potential to be used in therapy, 
but the application may be constrained by both medical and ethical issues (Seidl et al., 
2012). As an alternative, SHED can be used without arising any ethical concern. 
However, there are a limited number of studies conducted to investigate the migration 
of SHED during angiogenesis. The present  study, aims to investigate the migratory 
capacity of SHED within an in vitro environment, as well as analysing the regulation 
of gene that involved in cell migration and angiogenesis. 
1.2 Justification 
 The impeccable cellular properties of SHED in term of its migratory capacity 
and gene expression level during the proses of angiogenesis have not been fully 
understood. Despite the numerous studies conducted on other types of dental stem cell, 
the cellular migration of SHED during angiogenesis has not been documented in 
details. This study aims to obtain an insight into SHED’s behaviour during the 
formation of blood vessels and migration in wound healing. The simple monolayer 
model will mimic the condition during the process of wound healing. This process 
involves the migration of endothelial cells to the infected area but at the same time 
undergoing angiogenesis to produce new blood vessels. Screening of the gene markers 
expressed during these processes will help us to understand more about the 
complicated gene regulatory of SHED during the repair process. The gene markers 
selected for this study were rarely screened on SHED and some of them has never been 
detected on SHED before. The completion of this study will help researchers to 
understand the regulatory process involved and further exploit the process with the 




1.3.1 General objective 
To investigate the chemotaxis of stem cells from human exfoliated deciduous 
teeth (SHED) in 2D culture system with angiogenic differentiation medium.  
1.3.2 Specific objectives 
1. To determine the optimal seeding density of SHED in association with stem 
cell migratory capabilities during angiogenic differentiation. 
2. To assess the gene expression level of angiogenic, migratory and stem cell gene 
markers of SHED cultured in angiogenic differentiation medium.  
1.4 Research questions 
1. Does the migratory rate of SHED proportional to high/low seeding density? 
2. Can SHED maintain the gene expression of stem cell markers and express 
angiogenic and migratory markers following the angiogenic differentiation 
protocol? 
1.5 Hypothesis 
1. SHED migratory rate is proportional to high/low seeding density. 
2. SHED potentially maintained the gene expression of stem cell markers and 






        CHAPTER 2: LITERATURE REVIEW 
2.1 The cellular biology of wound repair 
Wound healing begins immediately at the moment of injury following surface lesions 
or just after exposure to radiation, chemical agents or extreme temperatures (Değim et 
al., 2002). Repair, in the context of healing of damaged tissue, can be defined as the 
restoration of tissue architecture and function after an injury which consists of two 
separate processes: regeneration and replacement (Krafts, 2010). A natural wound 
healing process is a complex and continuous activity involving blood coagulation, 
acute inflammation, cell migration, proliferation and differentiation, angiogenesis, re-
epithelialisation, synthesis and remodelling of extracellular matrix (ECM) (Maxson et 
al., 2012). In general, wound healing occurs in three phases: the inflammatory phase, 
the reparative phase, and the maturation phase, as shown in Figure 2.1. 
 
Figure 2. 1 Stages of wound healing. 
7 
 
2.1.1 The inflammatory phase 
Inflammatory is the first phase that takes place immediately after the injury, which 
consists of coagulation and hemostasis. Platelet aggregation and haemostasis cascade 
help to prevent local haemorrhage, and the blood clot contributes to the stopping of 
the bleeding and serves as a provisional matrix for the wound healing (Laurens et al., 
2006). Blood clot formation also enhances platelets adhesion and aggregation, which 
later form a procoagulant surface that produces thrombin and fibrin to help prevent 
blood loss at sites of vascular injury (Nurden et al., 2008). Arterial thrombus formation 
was initiated when the platelet adhesion on the reactive subendothelial matrix proteins 
(von Willebrand factor (VWF), collagens type I, III and VI) take place through the 
specific platelet receptors glycoproteins (GP) Ib-IX-V or GPVI (Savage et al., 1998).  
Next, sequential infiltration of neutrophils, macrophages and lymphocytes will take 
place to further supports an inflammatory reaction (Nishio et al., 2008). Neutrophils 
will carry out the antimicrobial activity to prevent wounds from infections (Wilgus et 
al., 2013). Another essential aspect of inflammatory phase is the presence of 
macrophage, a phagocytic cell that defence the host, promote and resolute the 
inflammation, as well as removing the apoptotic cells to support further cell 
proliferation and tissue restoration (Koh and DiPietro, 2011). The depletion of 
macrophage may result in increased levels of tumour necrosis factor-α (TNF-α) and 
reduced levels of both transforming growth factor-β1 (TGF-β1) and vascular 
endothelial growth factor (VEGF) in the wound, leading to delayed re-
epithelialisation, reduced collagen deposition, impaired angiogenesis, and decreased 
cell proliferation in the healing wounds (Mirza et al., 2009).  
8 
 
2.1.2 The reparative phase 
The reparative phase or also known as proliferative phase is marked by the initiation 
of fibroblast migration, followed by the deposition of newly synthesised ECM, and an 
abundant formation of granulation tissue (Velnar et al., 2009). Briefly, the diverse 
process of healing takes place during the reparative phase, starting with the 
proliferation and migration of keratinocytes at the wound edge through a process 
termed epithelialisation (Pastar et al., 2014; Werner and Grose, 2003). Re-
epithelialisation can be enhanced by the increase of TGF-β1 and microRNA-21 
together with the increased of dermal fibroblast infiltration into the wound (Reynolds 
et al., 2005; Yang et al., 2011). 
Following the migration of endothelial cells to the injury sites, angiogenesis will take 
place and further proliferate and differentiate to restore or create blood supply to the 
growing tissues (Crowther et al., 2001). The most potent angiogenic cytokines in 
wound angiogenesis include VEGF, TGF-β, angiopoietin and fibroblast growth factor 
(FGF) (Li et al., 2003b). Fibroblasts migrate into the wound tissue while producing 
the collagen-based ECM that ultimately replaces the provisional fibrin-based matrix 
and helps to reapproximate wound edges through their contractile properties (Baum 
and Arpey, 2005). Fibroblast gradually switches its dominant function to collagen 
production once they have migrated into the wound (Welch et al., 1990).  
The end of the proliferative phase is identified by the formation of granulation tissue 
(Sinno and Prakash, 2013). Within a few days, capillary sprouts begin to invade the 
fibrin/fibronectin-rich wound clot to form the organisation of microvascular network 
throughout the granulation tissue, leading to accumulation of collagen and production 
of immature ECM (Tonnesen et al., 2000). The newly formed ECM (provisional 
matrix) provides a scaffold or conduit for cell migration, and once an abundant 
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collagen matrix has been deposited in the wound, collagen production by the 
fibroblasts will be terminated, and the fibroblast-rich granulation tissue is replaced by 
a relatively acellular scar (Clark et al., 1982; Singer and Clark, 1999). 
2.1.3 The maturation phase 
Maturation or remodelling is the final phase of wound healing. This process will 
increase the wound strength for up to 2 years, with progressive organisation and 
development of the tissues (Steed, 1997). The remodelling of an acute wound 
maintains a balance between degradation and synthesis, increasing collagen bundles 
diameter, as well as the degradation of hyaluronic acid and fibronectin (Maxson et al., 
2012). Wound contraction occurs when abundant of ECM accumulation is reached by 
day 7, whereas fibroblasts transform into myofibroblast phenotype supplied with actin 
bundles that gather in the wound ECM by extending pseudopodia, attaching to ECM 
molecules, such as fibronectin and collagen (Clark, 1993). As the wound heals, 
apoptosis will further reduce the density of fibroblasts and macrophages  (Greenhalgh, 
1998). As time goes by, the growth of capillaries will stop, followed by reduced blood 
flow to the area and subsequent lower metabolic activity at the wound site (Falanga, 
1998).  
2.2  Tissue repair and regeneration 
Tissue engineering is a form of tissue regeneration using an approach consisting of a 
biocompatible scaffold, appropriate growth factors and suitable type of stem cells. 
Cell-based tissue engineering that has been widely applied in regenerative medicine 
such as neurology, orthopaedic and dentistry (Chen et al., 2015; Liu et al., 2016; Tatara 
and Mikos, 2016; Yamauchi et al., 2011). It is a relatively young field that combines 
engineering, clinical sciences and life sciences with the aim to repair or regrow tissues. 
A recent discovery in tissue reparative research provides a new era for therapeutic 
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medicine due to its rapid progress and the tremendous potential benefit involving all 
tissues in our body (Neel et al., 2014; Patrick, 2001). Tissue repair and regeneration 
following injury demand a precise orchestration of complex signalling cascades to 
coordinate the growth of structures that are spatially proximate but physiologically 
distinct (Rennert et al., 2012). The development of stem cells technologies and 
biomaterials can further design the tissue architecture where loss or damaged tissues 
will not be treated using only materials tolerated by the body but congregating 
biomaterials and biological principles to deliver to the body its original construction 
(Rosa, 2013). Hence, it is undeniably crucial for researchers to understand the role of 
each supporting elements in tissue engineering to ensure a successful outcome from 
the procedure.  
2.2.1 Stem cells in tissue repair 
Stem cell is one of the vital components of tissue repair. Stem cells are undifferentiated 
cells, which undergo asymmetrical cell division either to produce more stem cells or 
to differentiate to form specialised cells. The use of stem cells, which are often called 
‘master cells’ enable the clinical practitioner to achieve bone repair, as well as 
reconstruction of injured or pathologically damaged dental structure with 
predictability without compromising on donor site morbidity (Sreenivas et al., 2011). 
The cells are collected by isolating them from a patient or donor, followed by 
meticulous in vitro culture under appropriate conditions, and re-implantation into the 
defective sites of the patient to recover the previously normal function (Vishwakarma 
et al., 2015).  
2.2.1(a) Characterisation of Stem Cell 
Characterisation of stem cells is crucial, as it will provide the essential information on 
the cells’ niche, proliferation pattern, differentiation lineage and capacity. A defined 
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set of populations may provide a better understanding of the identity of the cells and 
reduce the risk of culturing contaminated cells. According to the guideline proposed 
by the Mesenchymal and Tissue Stem Cell Committee of the International Society for 
Cellular Therapy, the three minimum criteria for characterisation of stem cells involves 
the plastic-adherent in culture condition, positive expression of CD73, CD90 and 
CD105 surface molecules, and the confirmation on the self-renewal capacity and 
ability to differentiate into specific lineages (Baghaei et al., 2017).  
Since many changes observed in the protein level are not proportionate to the level of 
the corresponding mRNA, the gene expression data can be coupled with the protein 
analysis to have a better understanding of how the cell behaviour is regulated (Lu et 
al., 2009; van Hoof et al., 2012). For example, a study on human MSC from multiple 
lineages reveals the involvement of actin filament-associated protein, frizzled 7, 
dickkopf 3, protein tyrosine phosphatase receptor F, and RAB3B genes in promoting 
cell survival and influencing the commitment of MSC (Song et al., 2006). The results 
were confirmed on both gene and protein levels using RT-PCR and western blot.   
2.2.1(a)(i) Stem cell markers expression 
Human embryonic stem cells (hESCs) expressed several surface markers including 
various glycolipids and glycoproteins that were initially identified on human 
embryonal carcinoma cells or in human preimplantation embryos and the expression 
of specified surface markers is maintained in hES cells following prolonged periods 
of cultures (Hoffman and Carpenter, 2005). Pluripotent ESCs express markers 
including the nuclear transcription factors Oct4, Nanog and Sox2; the keratin sulfate 
antigens Tra-1-60 and Tra-1-81; and the glycolipid antigens SSEA3 and SSEA4 in 
human (Martí et al., 2013). Other than that, hESCs were also reported to expressed 
CD90, CD133, CD117 and CD135 (Carpenter et al., 2004). 
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Meanwhile, in adult stem cell, the commonly identified markers that are expressed in 
mesenchymal stem cells (MSCs) are CD105, CD73, CD44, CD45, CD90 (Thy-1), 
CD71, as well as the ganglioside GD2, CD271 and STRO-1 (Dissanayaka et al., 2012; 
Uccelli et al., 2008). One of the minimum characteristics of MSCs is a positive 
expression of CD105, CD73 and CD90, with lack expression of CD45, CD34, CD14 
or CD11b, CD79α or CD19 and HLA-DR surface molecules (Dominici et al., 2006).  
Ecto-5'-nucleotidase as a glycosylphosphatidylinositol-anchored membrane protein 
which is defined as the lymphocyte differentiation antigen (CD73). The primary 
function of CD73 is to catalyse the final step in the hydrolysis of ATP to adenosine 
and proved to be a positive marker for human MSCs (Ramos et al., 2016; Zhou et al., 
2007). MSC also expressed CD90 (Thy-1), a useful differentiation marker following 
the development of osteoblast (Wiesmann et al., 2006). The reduction in CD90 
expression enhances the osteogenic and adipogenic differentiation of MSCs in vitro 
which shows that CD90 controls the differentiation of MSCs by acting as an obstacle 
in the pathway of differentiation commitment (Moraes et al., 2016). Meanwhile, 
CD105 (endoglin) is known as the accessory receptor for TGF-β and positively 
expressed as MSCs-specific cell surface markers (Kays et al., 2014; Maleki et al., 
2014).  
2.2.1(a)(ii) Auto-renewal capacity and differentiation lineage 
Stem cells are well known for their ability to self-renew. This ability is essential in 
living organisms to be carried throughout the lifetime to repair damage tissues due to 
injury or illness. Self-renewal is the process by which a stem cell divides 
asymmetrically to generate one or two daughter stem cells that have a developmental 
potential similar to the mother cell (Shenghui et al., 2009). However, stem cells do not 
have an endless capacity to divide or can undergo constant self-renewal, but the self-
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renewal divisions are tightly regulated within the tissue to ensure lifelong maintenance 
(Fuchs and Chen, 2013). In fact, accumulation of DNA damage accompanies 
physiological stem cells ageing in human (Rübe et al., 2011). Plus, under stress 
condition, stem cells functional capacity was severely affected leading to the loss of 
proliferative potential, diminished self-renewal, increased apoptosis and functional 
exhaustion (Rossi et al., 2007). 
Another important characteristic of stem cells is the ability to differentiate into other 
types of cells. Pluripotent stem cells are stem cells that can differentiate into all types 
of lineage or the three embryonic germ layers; endoderm, mesoderm and ectoderm 
(Pera and Tam, 2010; Thomson et al., 1998). Two types of pluripotent stem cells 
include embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) 
(Evans and Kaufman, 1981; Romito and Cobellis, 2016; Takahashi and Yamanaka, 
2006). In vitro, human pluripotent stem cells have been successfully cultured in a 
thermoresponsive hydrogel culture system with the ability to retain the long-term, 
serial expansion and to differentiate into multiple cell lineages (Lei and Schaffer, 
2013). Meanwhile, multipotent stem cells are stem cells that can differentiate into all 
types of cells within one particular lineage (Khanlarkhani et al., 2016). Adult stem 
cells can be classified as multipotent stem cells owing to the limited ability to 
differentiate into one or more cell lines (Sobhani et al., 2017). Adipose-derived stem 
cell is one example of a multipotent adult stem cell. It can give rise to neuronal, 
osteogenic and adipogenic lineage (Huang et al., 2007; Kakudo et al., 2007; Lv et al., 
2015; Morandi et al., 2016).  
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2.2.1(b) The different types of stem cell 
Stem cells can be divided into three main types: ESCs that are derived from embryos; 
adult stem cells that are derived from adult tissues; and iPSCs that are generated 
artificially by reprogramming adult somatic cells into ESCs-like cells (Otsu et al., 
2014). In comparison to embryonic stem cell, adult stem cells are more preferred to be 
used clinically due to less ethical issues and low immunological responses (Deepika 
et al., 2015). Adult stem cells have been purified from various adult tissues such as 
bone, blood and dental origin (De Wynter et al., 1995; Simpson et al., 2012; Wang et 
al., 2017; Zhao et al., 2017). The two most common types of adult stem cells, with 
distinct identified differentiation lineage, are the hematopoietic stem cell (HSC) and 
mesenchymal stem cells (MSCs) (Ulloa-Montoya et al., 2007).      
HSC is defined as cells that can undergo self-renewal and generate differentiated 
progeny of multiple blood cell lineages (myeloid and lymphoid) (Keller, 1992). HSCs 
occupy multiple niches, including sinusoidal endothelium such as spleen and bone 
marrow as well as endosteum (Kiel et al., 2005). Immature HSC, located in the bone 
marrow after birth maintains the adequate production of blood cells besides being able 
to reconstitute the hematopoietic system in disease-related bone marrow failure and 
bone marrow aplasia (Gunsilius et al., 2001). Other than that, HSC that reside 
primarily in the bone marrow do circulate in the peripheral blood and can replenish 
damaged or missing components of the hematopoietic and immunologic system 
(Trigg, 2004).  
MSCs, a type of multipotent stem cell that is found within the bone marrow 
microenvironment, defined by its ability to differentiate into the osteogenic, 
chondrogenic, tendonogenic, adipogenic, myogenic and endothelial cell lineages 
(Majumdar et al., 1998; Oswald et al., 2004). Compared to other types of adult stem 
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cell, MSC and MSC-like cells offer better therapeutic potential as they can 
differentiate not only into mesenchymal lineages but also into ectodermal and 
endodermal derivatives, as well as regeneration of other connective tissues such as 
dentin, cementum and periodontal ligament (Chanda et al., 2010; Shi et al., 2005). 
Bone marrow, umbilical cord blood and adipose tissue are among the known sources 
of MSCs (Dharmasaroja, 2009; Erices et al., 2000; Kern et al., 2006; Zuk et al., 2002).  
On top of that, brain, spleen, liver, kidney, lung, bone marrow, muscle, thymus, 
pancreas are the different organs and tissues reported to be the source of cells with 
mesenchymal stem characteristics (da Silva Meirelles et al., 2006). In vivo, MSCs stain 
positive by flow cytometry for haematopoietic markers CD29, CD73, CD90, CD105 
and CD166. MSCs also demonstrate prolonged skin allograft survival and possess 
several immunomodulatory effects (Le Blanc and Ringden, 2007). Interactions of 
human MSCs with the various immune cells are shown to inhibit the inflammatory 
responses and promote the anti-inflammatory pathways (Aggarwal and Pittenger, 
2005). Among other sources of stem cells, dental tissue has been identified as a rich 
source for the adult stem cells with mesenchymal stem cell characteristics. 
2.2.1(c) Stem cells from the oral and maxillofacial region 
Dental stem cells were successfully isolated from various sources within the oral and 
maxilla facial region, which includes the dental pulp, exfoliated deciduous teeth 
(SHED), the periodontal ligament, the dental follicle and the dental papilla and many 
more (Chadipiralla et al., 2010; Mangano et al., 2010; Morsczeck et al., 2010; Yagyuu 
et al., 2010). This mesenchymal-stem-cell-like population exhibits the capacity for 
self-renewal and multilineage differentiation potential (Huang et al., 2009; Ulmer et 
al., 2009). The next section will briefly introduce the different types of dental stem 
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cells. These stem cells have been purified and characterised for their potential role in 
tissue repair and regeneration. Figure 2.2 displays the different sources of stem cells 
from the oral and maxillofacial region.  
 
 
Figure 2. 2 Sources of dental stem cells. Reproduced from Sharpe (2016). 
 
2.2.1(c)(i) Stem cell from human exfoliated deciduous teeth (SHED)  
SHED possess mesenchymal-like characteristics with potential benefit for clinical 
applications, owing to the feasibility of isolation and less ethical concern. SHED are 
highly proliferative multipotent cells derived from primary teeth that usually being 
discarded (Rosa et al., 2016). SHED express two early mesenchymal stem-cell 
markers, the cell surface molecules STRO-1 and CD146 (MUC18) (Miura et al., 
2003b). SHED offer massive potential for development, owing to their rapid 
maturation as opposed to other types of adult stem cells (Yin et al., 2016). Besides, 
SHED can also be preserved for up to 3 years using cryopreservation techniques, 
without affecting the biological, immunological and therapeutic function of the cells 
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(Ma et al., 2012). Reports indicated no significant differences between characteristics 
and population doubling time of cryopreserved SHED and fresh SHED (Lee et al., 
2015; Lee et al., 2011b).   
SHED is an ideal candidate to repair damaged tooth structures, induce bone 
regeneration and possibly treat neuronal tissue injury or degenerative diseases. SHED 
have high proliferation ability and can differentiate in vitro and in vivo, forming 
neurons, adipocytes, odontoblasts, osteoblast and chondrocytes (Silva, 2015; Yu et al., 
2014). Moreover, SHED has been proven to be able to differentiate into angiogenic 
endothelial cells, odontoblasts and smooth muscle cells for vascular tissue engineering 
(Sakai et al., 2010; Xu et al., 2017). A clearly defined characteristics and biological 
activity of SHED may enable their application in cell-based repair treatment, pretty 
much sooner than expected. 
2.2.1(c)(ii) Dental Pulp Stem Cell (DPSC)  
Dental pulp stem cell which resides within the perivascular niche of the dental pulp is 
thought to arrive from migrating cranial neural crest (CNC) cells.  DPSC provides a 
readily accessible source of exogenous stem/precursor cells for therapeutic paradigms 
to treat neurological disease (Arthur et al., 2008). DPSC remain detectable in humans 
up to the age of 30, by producing sporadic calcified nodules in vitro and forming a 
mineralised tissue after transplantation in vivo (Laino et al., 2005). Under chemically 
defined culture condition, DPSCs can be induced to undergo normal differentiation 
into smooth and skeletal muscles, neurons, cartilage and bone in vitro while showing 
dense engraftment in various tissues after in vivo transplantation of these cells into 
immunocompromised mice (Kerkis et al., 2006). DPSCs are ideal for tissue 
reconstruction as they possess easy access to the collection site, produces very low 
morbidity, highly efficient extraction of stem cells from pulp tissue, extensive 
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differentiation ability and the desirable interactivity with biomaterials (d’Aquino et al., 
2008). 
2.2.1(c)(iii) Stem cells from apical papilla (SCAP) 
Stem cells from apical papilla is a population of stem cells isolated from the apical 
root papilla of human teeth. SCAP expressed MSC markers such as STRO-1, ALP, 
CD24, CD29, CD73, CD90, CD105, CD106, CD146, CD166 and ALP. The 
population of SCAP appear to have a greater capacity for dentin regeneration than 
DPSC since they can form odontoblast-like cells, are likely to be the cell source of 
primary odontoblasts for the root dentin formation as it produced dentin in vivo 
(Sonoyama et al., 2006; Sonoyama et al., 2008). SCAP is the primary source of 
odontoblasts that are responsible for the formation of root dentin (Huang et al., 2008). 
SCAP cultures also showed a significantly higher proliferation rate and mineralisation 
potential compared to DPSC which might be of significance for their use in 
bone/dental tissue engineering (Bakopoulou et al., 2011).  
2.2.1(c)(iv) Periodontal ligament stem cell (PDLSC) 
The periodontal ligament stem cell is another type of stem cell from the dental origin. 
PDLSC represent a unique mesenchymal stem cell population as demonstrated by their 
capacity to differentiate into a cementoblast-like cells/periodontal ligament-like tissue, 
adipocytes and collagen-forming cells in vivo, contribute to periodontal tissue repair 
while displaying cell surface marker characteristics (STRO-1 and CD146/MUC18) 
and differentiation potential similar to bone marrow stromal stem cells (BMSSCs) and 
DPSC (Seo et al., 2004; Wada et al., 2009). PDLSC are capable of regenerating 
periodontal tissues, leading to favourable treatment for periodontitis (Gay et al., 2007; 
Liu et al., 2008). PDLSC can also repair allogeneic bone defects in an experimental 
model of periodontitis without causing immunological rejections, likely due to the low 
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immunogenicity and immunosuppressive function possessed by PDLSCs (Ding et al., 
2010).   
2.2.1(c)(v) Dental follicle precursor cells (DFPC)  
Dental follicle precursor cells can differentiate and form healthy connective tissues 
and produce clusters of mineralised tissue (Morsczeck et al., 2009). DFPC derived 
from neural crest cells is a type of transient cell population in developing vertebrates 
and progenitors for the peripheral nervous system. These type of cells are favourable 
for neural differentiation and neural tissue regeneration due to the ability to perform 
transdifferentiation into epithelial-like cells (Beck et al., 2011). DFPC represent cells 
from a developing tissue which is in common with SCAP and might be more plasticity 
than other dental stem cells, owing to the ability to form the periodontal ligament 
(PDL) by differentiating into PDL fibroblasts that secrete collagen and interact with 
fibres on the surfaces of adjacent bone and cementum (Estrela et al., 2011). There are 
no ethical issues regarding DFPC isolation since dental follicle is present in impacted 
teeth which are commonly extracted and disposed of as medical waste (Bojic et al., 
2014).  
2.2.2 Growth factors in tissue repair 
Cytokines are small proteins that are released by cells that specifically affected the 
interactions and communications between cells (Zhang and An, 2007). Growth factors 
are cytokines that stimulate cell growth and are widely used in clinical practice, such 
as treatment of nervous system disease, wound healing, revascularisation, and bone 
repair (Zhao et al., 2015). The delivery of growth factors can regulate the provision of 
environment for cell development (Lee et al., 2011a). In some cases, growth factors 
that are combined with scaffold demonstrate an increase new bone formation by 
promoting the infiltration of the cell into the scaffold as well as the differentiation of 
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progenitor cells into a specific cell and tissue type (Blackwood et al., 2012). Growth 
factor also plays a vital role in tissue repair as the exogenous growth factor may further 
support the proliferation of cellular components that involved in tissue development 
and the healing process (Chen et al., 2010).  
Several examples of cytokines involved in angiogenesis of tissue repair include 
Angiopoietin-1, Interleukin-8 and VE-Cadherin. Angiopoietin-1 (Ang-1) is an 
angiogenic factor that signals through the endothelial cell-specific Tie2 receptor, a 
tyrosine kinase that is essential for normal vascular development in the mouse similar 
to VEGF (Maisonpierre et al., 1997). Ang-1 also prevent apoptosis, support vascular 
sprouting or branching and stabilise the blood vessels (Babaei et al., 2003; Taura et 
al., 2008). Other than that, Ang-1 requisitely collaborate with VEGF during blood 
vessel development; thus Ang-1 mRNA was expressed in tumour cells (Gale et al., 
2002; Stratmann et al., 1998).  
Interleukin-8 (IL-8) promotes angiogenic responses in endothelial cells, infiltrates 
neutrophils at the tumour site and also enhances the proliferation, survival and 
apoptosis inhibitor of CXCR1- and CXCR2-expressing endothelial cells (Li et al., 
2003a; Waugh and Wilson, 2008). Besides, IL-8 is an important pro-angiogenic 
mediator which increase endothelial permeability during the early stage of 
angiogenesis and induces the migration and proliferation of endothelial cells and 
smooth muscle cells (Petreaca et al., 2007; Simonini et al., 2000). 
Vascular Endothelial (VE)-Cadherin mediates specific intracellular signalling in the 
endothelium that modulate the functional reactivity (Lampugnani and Dejana, 1997). 
VE-Cadherin is an essential adhesive molecule at the inter-endothelial adherent 
junction as it controls vascular integrity and normal organ function (Corada et al., 
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1999). In addition, the control of vascular integrity and vascular permeability requires 
the expression of VE-Cadherin since it can transfer information intracellularly through 
interaction with a complex network of cytoskeletal and signalling molecules (Dejana 
et al., 1999). 
Whereas, CCR1, CXCR4 and CCL28 are several examples of cytokines involved in 
the cell migration of tissue repair. CCR1 can promote the migration of monocytes, 
macrophages and T cells (Schall and Proudfoot, 2011). Overexpression of CCR1 
increased the migration of murine MSC, protected it from apoptosis and also enhanced 
the survival and engraftment of MSC (Huang et al., 2010a). Other than that, CCR1 
was proven to be correlated to structural changes in the airway suggests that CCR1-
positive cells have an active role in tissue remodelling and together with CCR4, they 
form functional receptors on human cord-blast derived mast cells with the capacity to 
mediate migration towards CCL5 (Amin et al., 2005; Juremalm et al., 2002).   
CXCR4 is important in the migration, homing, survival and development of multiple 
cell types including in the nucleus of the migrating hematopoietic stem cell, and have 
a dynamic expression that regulated by both autocrine and paracrine mechanisms to 
induce multiple cell responses (Bhakta et al., 2006; Dar et al., 2006). In vivo, 
intravenous infusion of MSC with CXCR4 overexpression leads to increased in the 
number of MSC homing in the infarct region, decreased in anterior wall thinning and 
improved chamber compliance following coronary occlusion in rats (Cheng et al., 
2008). 
CCL28 was expressed in the large and small intestine as it is important in maintaining 
gut immunity and promoting immune cell migration (Nagafusa and Sayama, 2020). 
CCL28 production that was regulated by NF-kB pathway plays a crucial role following 
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spinal cord injury by recruiting CCR10-expressing and immunosuppressive Treg cells 
(Nagafusa and Sayama, 2020). Besides, CCL28 signalling via its primary receptor, 
CCR10 promotes wound angiogenesis in endothelial cells through endothelial Nitric 
Oxide Synthase-dependent Src, p13K and MAPK signalling (Chen et al., 2020).  
2.2.3 Scaffold in tissue repair 
Scaffolds for tissue repair and regeneration are designed to influence the physical, 
chemical and biological environment surrounding a cell population (Howard et al., 
2008). An ideal biomaterial scaffold will provide mechanical support to an injured site 
and also deliver growth factors and cells into a defect to encourage tissue growth 
besides degrading in a controlled manner without causing a significant inflammatory 
response (Mistry and Mikos, 2005). There are two types of scaffold used in the 
reparative process; either originated from natural resources or synthetically created 
(Dhandayuthapani et al., 2011). Some example of biological scaffold includes human 
amniotic membrane (HAM) that were used in cartilage repair and regeneration studies 
(Díaz-Prado et al., 2010; Jin et al., 2007). Chitosan is also a type of natural scaffold 
used in melanocyte transplantation and biocompatibility study in mice (Lin et al., 
2005; VandeVord et al., 2002).  
Other than that, extracellular matrix (ECM) was also successfully used as a natural 
scaffold in facilitating the recruitment of marrow-derived cells into remodelling sites 
in mice and restoration of the musculotendinous junction in canine  (Badylak et al., 
2001; Turner et al., 2010). As for synthetic scaffold, peptide, polycaprolactone, 
hydrogel, composite silk and nano/micro-fibre-combined scaffolds had been used in 
various in vitro and in vivo tissue repair studies (Rustad et al., 2012; Santos et al., 
2008; Schantz et al., 2007; Seo et al., 2009; Wang et al., 2008).  Positive remodelling, 
vascular formation, and tissue repair depend significantly on the ability of cells to 
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migrate into or through the injected scaffold material in vivo (Singelyn and Christman, 
2011).  
2.3 Angiogenesis study in tissue repair  
Angiogenesis is new capillaries sprouting from a pre-existing blood vessel that 
includes complex multistep processes involving remodelling of the extracellular 
matrix, migration and proliferation of endothelial cells, lumen formation and 
functional maturation of blood vessels (Breier and Risau, 1996). Studies of 
angiogenesis in stem cell-based tissue repair mainly focus on ensuring the survival and 
functional capacity of transplanted tissues in the treatment of angiogenic-related 
diseases, such as stroke, cardiovascular diseases and wound healing by using stem 
cells (Fatimah et al., 2013). The increased of angiogenesis following transplantation 
can help to relieve the symptoms of ischemia through the supply of oxygen and 
nutrients which lead to the restoration of damaged tissues (Reddy et al., 2020). 
2.3.1 In vitro monolayer and 3D culture 
As the importance of the angiogenesis process in tissue repair has been well known, 
various studies had been performed to investigate the mechanism and other relevant 
factors influencing the process. The vast majority of earlier angiogenesis studies were 
conducted using the approach of culturing monolayer cells directly on the plastic 
surface (Gajdusek et al., 1993; Merwin et al., 1990; O'Connor et al., 2000). MSC 
monolayer studies have been used to show the angiogenic function of BMSCs in direct 
and indirect co-cultures and to prove that BMSCs are able to maintain their lineage-
specific angiogenic differentiation (Böhrnsen and Schliephake, 2016). However, as 
more information is successfully gathered on the characteristics of the cells, 
researchers started to use scaffold or 3D culture to study the process in a more complex 
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environment. MSCs significantly demonstrated lower expression of VEGF, SDF, and 
HGF, compared to spheroid-cultured-MSCs (Lee et al., 2016).   
In order to mimic the complex extracellular matrix structure, scaffold, one of the key 
components in tissue engineering, has been introduced to in vitro stem cell studies. In 
previous years, Matrigel scaffold has been successfully described in detail for their 
application in 3D angiogenesis studies using cells of various origins, including human 
umbilical vein endothelial cell (HUVEC), MSC, adipose-derived stem cell (ADSC), 
muscle-derived satellite cells and other types of adult stem cells from human and rat 
(Cai et al., 2015; Liang et al., 2007b; Mohammadi et al., 2015; Oswald et al., 2004; 
Tapon-Bretaudière et al., 2002). From time to time, various types of scaffolds have 
been tested for angiogenic induction protocol. For instance, peptide-amphiphile (PA) 
and growth factor infused transparent 3D hydrogel was found to exhibit a significant 
increase of angiogenesis around the injected site, at the back of experimental mice 
(Hosseinkhani et al., 2006). 
2.3.2 In vitro angiogenic induction protocol 
Diverse methods have been used over the years to induce angiogenesis within the in 
vitro culture. VEGF is the classic inducer of angiogenesis that is used widely in the 
angiogenic study. It has been proved that VEGF actively enhances angiogenesis of 
endothelial cell (Ferrara et al., 2003). Magnetic resonance imaging (MRI) was used to 
measure the effects of VEGF on angiogenesis of embolic ischemic rats, and it was 
found that VEGF accelerated the angiogenesis in the ischemic brain and lowered 
neurological deficits during stroke recovery (Zhang et al., 2000). EGM2 medium is 
another inducer used in the induction of angiogenesis (Arnaoutova and Kleinman, 
2010; Souza et al., 2018). A study on angiogenic differentiation of human MSC 
